Most of the drugs that exited the market are nervous system medicines (204), cardiovascular drugs (143), digestive system (49) and cancer drugs (40).
Most of the medicines registered in Romania in 2011 and 2012 are generic drugs, ANMDM said.
According to market research company Cegedim, nervous system, cardiovascular, digestive system and cancer drugs account for 60% of the Romanian drug market, with cumulated sales of 7.3 billion lei (EUR1.65 billion).
The Romanian pharmaceutical market stood at RON11.7 billion last year. (EUR1=RON4.4228)